fluticasone-salmeterol Advair
Selected indexed studies
- Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. (N Engl J Med, 2016) [PMID:27181606]
- Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler. (JAMA Intern Med, 2025) [PMID:40622686]
- COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada. (Respir Med, 2014) [PMID:25175480]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Salmeterol-Fluticasone: The Role Revisited. (2022) pubmed
- Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. (2016) pubmed
- Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study. (2020) pubmed
- Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler. (2025) pubmed
- COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada. (2014) pubmed
- Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies. (2020) pubmed
- Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. (2001) pubmed
- Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick(®)): A Review in Asthma. (2018) pubmed
- Salmeterol/fluticasone propionate: a review of its use in asthma. (2009) pubmed
- Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability. (2024) pubmed